Home Up Contents Euro Prices Order Info Distributors

 Cortisol RIA test

GENTAUR Belgium : + 32 2 7325688 France : 01 43250150 Italy : 02 36006593 • Germany : +49 241 6085 13140

Up

 

TEL: +32 16 58 90 45

Fax :+ 32 16 50 90 45

GENTAUR Europe

tel+32 2 732 5688
fax+32 2 732 4414
info@genprice.com
Av. de l' Armée 68
B-1040 BRUSSELS
BELGIUM

GENTAUR France

tel 01 43 25 01 50

fax01 43 25 01 60

9, rue Lagrange

75005 PARIS

FRANCE

GENTAUR Italy

tel 02 36 00 65 93

fax 02 36 00 65 94

20135 MILANO

ITALY

GENTAUR Germany

tel +49 241 6085 13140

fax +49 241 6085 33033

Forckenbeckstraße 6,

D-52074 Aachen

GERMANY


 

 

Description

The cortisol [125I] assay system provides the quantitative in vitro determination of cortisol in human serum. Cortisol can be assayed in the range 0-1600 nmol/l (0-580 ng/ml). Each kit contains materials sufficient for 100 assay tubes, permitting the construction of one standard curve and assay of 42 unknowns and 1 control in duplicate.

Introduction

Cortisol is the main glucocorticoid which is produced by the adrenal cortex. It regulates carbohydrate, protein, fat and purine metabolism, electrolyte and water balance. Cortisol has a role in blood pressure regulation and resolution of inflammation.

The determination of cortisol levels can be used for diagnosing the functional disturbances of the hypothalamus-pituitary-adrenal cortex (HPA) axis.

In normal individuals cortisol secretion has a characteristic rhythm: the cortisol level is the highest in the morning, by the evening it decreases to approximately half that level.

Principle of the method

This assay is based on the competition between unlabelled cortisol and a fixed quantity of 125I-labelled cortisol for a limited number of binding sites on cortisol specific antibody. Allowing to react a fixed amount of tracer and antibody with different amounts of unlabelled ligand the amount of tracer bound by the antibody will be inversely proportional to the concentration of unlabelled ligand. Upon addition of magnetiz­able immunosorbent the antigen-antibody complex is bound on solid particles which are then separated by either magnetic sedimentation or centrifugation. Counting the radioactivity of solid phase enables a standard curve to be constructed and samples to be quantitated.

Contents of the kit

1 vial TRACER, ready to use
11 ml, containing about 115 kBq 125I-cortisol in buffer with 0.1% NaN3
6 vials STANDARDS, ready to use
0.5 ml per vial, containing 0, 40, 100, 250, 650, 1600 nmol/l in serum with 0.1% NaN3
1 vial ANTISERUM, ready to use
11 ml, containing polyclonal anti-Cortisol (rabbit) IgG in buffer with 0.1% NaN3
1 vial CONTROL SERUM. Lyophilised human serum with 0.1% NaN3
1 bottle MAGNETIC MMUNOSORBENT (MIS), ready to use
55 ml, containing paramagnetic particles in buffer with 0.1% NaN3.
  Quality certificate
  Pack leaflet

Materials and equipment required

Round bottom polystyrene or polypropylene assay tubes, about 12 x 75 mm
Plastic film to cover tubes
Precision pipettes (10, 100 and 500 µl)
Vortex mixer
Magnetic separator (or, alternatively, centrifuge)
Decanting racks
Gamma counter

Recommended tools and equipment

Orbital shaker
Repeating pipettes

Preparation of reagents

Add 500 µl distilled water to the lyophilised control serum. Mix gently with shaking or vortexing (foaming should be avoided). Ensure that complete dissolution is achieved, and allow the solution to equilibrate at room temperature for at least 20 minutes.

For repeated use the rest of reagent can be stored at 4-8 oC for two months.

Specimen collection and storage

Serum samples can be prepared according to common procedures used routinely in clinical laboratory practice.Sera can be stored at 2-8 oC for two days after collection. For later analysis they should be stored deep-frozen. Repeated freezing and thawing should be avoided. Do not use lipemic, hemolyzed or turbid specimens.

Assay procedure

(For a quick guide refer to Table 1)

1 Equilibrate all reagents to room temperature
2 Label duplicate tubes for total counts (T), zero standard (Standard 1 = B0), standards (S2-6), control (C) and samples (Sx).
3 Mix all reagents and samples thorougly before use. Avoid excessive foaming.
4 Pipette 10 µl each of standards, control and samples into the properly labelled tubes.
5 Pipette 100 µl of tracer solution into all tubes.
6 Pipette 100 µl of antiserum into all tubes except T.
7 Thoroughly vortex mix all tubes except T for 2-5 seconds. When having an orbital shaker, leave all tubes in the rack holder, fix the holder onto the plate of the shaker, and shake it gently for a few seconds.
8 Incubate the tubes for 2 hours at room temperature.
9 Place T tubes on a separate tube rack. Gently shake and swirl the bottle containing magnetic immunosorbent until homogeneity. Add 500 µl to each tube except T. When using a single pipette, swirl the bottle of MIS after every 15-20 tubes. With the use of a repeating pipette (e.g. Eppendorf), there is no need for repeated homogenisation of MIS reagent.
10 Thoroughly vortex mix all tubes and incubate them for 15 minutes at room temperature.
11 Separate the bound fraction by using one of the following procedures.
Magnetic separation
Attach the rack on to the magnetic separator base and ensure that every tube is in contact with the base plate. Let the MIS particles settle for 5 minutes. Do not remove the rack from the separator base after the separation of the solid and liquid phases. Pour off and discard the supernatant. Keeping the separator inverted, place the tubes on a pad of absorbent tissue and allow to drain for 2 minutes.
Centrifugation
Centrifuge all tubes for 15 minutes at 1500 g or greater. Aspirate the supernatant taking care to avoid disturbing the precipitate.
12 Count the radioactivity of all tubes preferably not less than 60 seconds
13 Calculate the concentrations as described under Calculation of results.

Table 1. Assay Protocol, Pipetting Guide (all volumes in microliters)

Tubes

T

S1-S6

Sx

C

Standard

 

10

   

Sample

   

10

 

Control

     

10

Tracer

100

100

100

100

Antiserum

 

100

100

100

Vortex mix
Incubate for 2 hours at room temperature

Magnetic Immunosorbent

 

500

500

500

Vortex mix
Incubate for 15 minutes at room temperature

Place the tubes on the magnetic separator for 5 minutes or centrifuge for 15 minutes at 1500 g

Decant the supernatant and blot the tubes

Count all tubes

Calculation of results

The assay data collected should be similar to those shown in Table 2. Calculate the average counts per minute (CPM) for each pair of assay tubes.

Calculate the percent B0/T for zero standard (S1) by using the following equation:

  S1 (cpm)  
B0 / T % =  ———   x 100
  T (cpm)  

Calculate the normalized percent binding for each standard, control and sample respectively by using the following equation:

  S2-6 [C, Mx] (cpm)  
B / B0 % =  ——————————   x 100
  S1 (cpm)  

For simplicity, these values are uncorrected for non-specific binding (NSB). This is enabled by low NSB being less than 3% of total count.

Using semi-logarithmic graph paper plot B / B0% for each standard versus the corresponding concentration of cortisol. Figure 1 shows a typical standard curve.

Determine the cortisol concentration of the unknown samples by interpolation from the standard curve. Do not extrapolate values beyond the standard curve range. Automated data processing systems are also available.

Table 2. Typical Assay Data

Tubes Counts CPM1 Counts CPM2 Counts CPM

B/T%

B/B0 %

T

45762

45262

45512

S1

28959

30112

29536

64.9

100.0

S2

21096

20753

20925

46.0

70.8

S3

11349

11896

11623

25.5

39.4

S4

6054

6112

6083

13.4

20.6

S5

3293

3344

3319

7.3

11.2

S6

2078

2046

2062

4.5

7.0

C

4935

5045

4990

11.0

16.9

Typical standard curve for the Cortisol I-125 RIA kit
Cortisol concentration nmol/l

Figure 1.
A typical standard curve
(Do not use to calculate sample values)

Conversion of SI units can be performed according to the following formula:
1 nmol/l = 0.362 ng/ml

Characterization of the assay

Assay parameters

NSB/T < 3 %
B0 / T 62.8 ± 5 %
ED-50 130.5 ± 18 nmol/l

Specificity

Cross reactivity of the cortisol antiserum in the kit with various substances are shown below:

Basal steroid concentration

20 ng/ml

200 ng/ml

Apparent cortisol concentration (ng/ml)

Prednisolone

19.1

166.5

Corticosterone

7.9

27.0

Desoxycorticosterone

5.0

12.3

17a-OH-progesterone

7.6

14.4

Progesterone

4.7

6.1

17a-estradiol

< 3.6

< 3.6

Estriol

< 3.6

3.6

Estrone

< 3.6

3.9

Testosterone

< 3.6

4.7

Dehydroepiandrosterone

< 3.6

< 3.6

Sensitivity

10 nmol/l, defined as the concentration 2 standard deviations from the zero standard.

Precision, reproducibility

Intra-assay
(1 assay in 21 rep.)

Inter-assay
(17 assays in 2 rep.)

Mean (ng/ml)

CV %

Mean
(ng/ml)

CV %

73.8 6.1 81.0 5.2
138.7 5.2 491.7 7.1
727.8 8.8 759.1 10.8

Recovery

Recovery was defined as the measured increase expressed as percent of expected increase upon spiking serum samples with known amount of cortisol. Values for 11 serum samples spiked with cortisol at 3 levels were: 101 ± 10 %

Expected reference values

It is recommended that each laboratory establish its own reference intervals. As a guide,

morning values: 160-620 nmol/l (58-225 ng/ml)
evening values: 90-400 nmol/l (33-145 ng/ml)

was obtained from normal patients.

The results obtained should only be interpreted in the context of the overall clinical picture. None of the in vitro diagnostic kits can be used as the one and only proof of any disease or disorder.

Additional information

Storage

Store the reagents between 2 and 8 °C. At this temperature each reagent is stable until expiry date. Pay special attention to preventing magnetic immunosorbent suspension from freezing.

Availability

From stock.

Shelf life

The shelf life of kit reagents is 8 weeks from the date of manufacturing. To make maximum benefit of long-term stability it is recommended to adjust the date of ordering to labelling calendar issued each year. The actual expiry date is given on package label and in the quality certificate. Components from various lots or from kits of different manufacturers should not be mixed or interchanged.

Precautions and warnings

This kit should only be used for in vitro diagnostic purposes.

Radioactivity

This kit contains radioactive material. Receipt, acquisition, possession, or use of radioactive materials are subject to regulations, and a licence of (inter)national authorizing bodies. It is the responsibility of the user to ensure that local regulations or codes of practice are satisfied.

Potentially infectious materials

Human blood products provided as components of this product have been obtained from donors tested individually and found negative for Human Immunodeficiency Virus antibody (HIV-Ab) as well as for Hepatitis B surface Antigen (HBsAg) using approved EIA methods.

Care should always be taken when handling human specimens to be tested with diagnostic kits. Even if the subject has been tested, no method can offer complete assurance that Hepatitis B Virus, Human Immunodeficiency Virus (HIV), or other infectious agents are absent, and all human blood samples should be considered potentially infectious.

Chemical and other hazard

Some components contain sodium azide (0.1% w/v) as an antimicrobial agent. Dispose the waste by flushing it with copious amounts of water to avoid build up of explosive metallic azides in copper and lead plumbing. The total azide present in each pack is 80.5 mg.

 

Use by In vitro diagnostic medical device Control
Batch code Manufacturer Standard
Caution, consult accompanying documents Radioactive material Magnetic immunosorbent
Biological risk Temperature limitation
Store between 2-8 °C
Tracer
Consult operating instructions Catalogue number Antiserum

Cortisol RIA test

© 2005 GENTAUR bvba
 

Bioxys, HIV p24, TNF a, IFN gamma, Agarose